Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-01-16 | New | $56,979,133 | $56,979,133 | Equity Only | 06b | SEC link |
| 2024-09-17 | New | $66,000,000 | $66,000,000 | Equity Only | 06b | SEC link |
| 2024-09-17 | New | $65,999,999 | $65,999,999 | Equity Only | 06b | SEC link |
| 2021-10-04 | New | $34,500,000 | $34,500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Allen Cunningham | Director, Executive |
| Jayson Dallas | Director, Executive |
| Francesco De Rubertis | Director |
| Derek Di Rocco | Director |
| Patrick Enright | Director |
| Nancy Hargreaves | Executive |
| Shaharyar Khan | Director, Executive |
| Erin Lavelle | Director |
| Tom O'neil | Executive |
| Robert Schott | Executive |
| Ian Smith | Director |
| Rick Winningham | Director |